Agreed. I don't think they are up to Litarion's level either and LECN reported losses. OGES lost $29M on Leclanche in 2015 (8/23 10Q OGES Filings). IMO, LECN might be underbidding, maybe the way they won the IESO Canada deal over EFL. Leclanche claims 15,000 cycles @100% DoD with LTO in their presentation and might be weighted to produce more of that. It might still in be in their plan to continue to work with Litarion. This is from their latest Interim Report:
-
"The Company will increasingly source, rather than manufacture in-house, high energy density cells by taking advantage of the increasing supply of high quality and competitively priced graphite NMC cells from best-in-breed suppliers. The in-house production capacity will be primarily used for production of industry-leading lithium titanate oxide (LTO) cells."
